These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305 [TBL] [Abstract][Full Text] [Related]
4. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related]
5. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Vasudev K; Goswami U; Kohli K Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972 [TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [TBL] [Abstract][Full Text] [Related]
7. Valproate for acute mood episodes in bipolar disorder. Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186 [TBL] [Abstract][Full Text] [Related]
10. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. Maina G; Albert U; Salvi V; Mancini M; Bogetto F J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122 [TBL] [Abstract][Full Text] [Related]
11. Lithium for acute mania. McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444 [TBL] [Abstract][Full Text] [Related]
12. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047 [TBL] [Abstract][Full Text] [Related]
14. Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies. Kowatch RA; Carmody TJ; Suppes T; Hume JH; Kromelis M; Emslie GJ; Weinberg WA Acta Neuropsychiatr; 2000 Sep; 12(3):145-9. PubMed ID: 26975276 [TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
16. Topiramate versus Valproate Sodium as Adjunctive Therapies to a Combination of Lithium and Risperidone for Adolescents with Bipolar I Disorder: Effects on Weight and Serum Lipid Profiles. Mahmoudi-Gharaei J; Shahrivar Z; Faghihi T; Mohammadi MR; Tehrani-Doost M; Alaghband-Rad J; Ghaeli P Iran J Psychiatry; 2012; 7(1):1-10. PubMed ID: 23056111 [TBL] [Abstract][Full Text] [Related]
17. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH; McNamara RK; Watterson JM; Watson DG J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [TBL] [Abstract][Full Text] [Related]
18. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study. Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Geller B; Luby JL; Joshi P; Wagner KD; Emslie G; Walkup JT; Axelson DA; Bolhofner K; Robb A; Wolf DV; Riddle MA; Birmaher B; Nusrat N; Ryan ND; Vitiello B; Tillman R; Lavori P Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771 [TBL] [Abstract][Full Text] [Related]
20. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]